Waselius represented Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies in its additional equity financing of an aggregate of EUR 13.4 million.
Lawyer involved
In Focus
Navigation
Waselius represented Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies in its additional equity financing of an aggregate of EUR 13.4 million.
Lawyer involved
| Cookie | Duration | Description |
|---|---|---|
| _lfa | 2 years | Marketing & analytics (website visitor tracking) using Leadfeeder |